Comparison Between Vaginal and Sublingual Misoprostol 50 µg for Cervical Ripening Prior to Induction of Labor
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
To analyze whether there is a statistically significant difference in the modifications
present in the uterine cervix 6 hours after administration of misoprostol 50 µg through
vaginal versus sublingual routes.